The purpose of the study is to assess the usability of the PNA and satisfaction with the treatment within the framework of usual care remote nutritional counselling for GLP-1-supported weight management and collect pilot data on its potential to support weight loss.
No linked publications found in PubMed
Inclusion Criteria: * Written informed consent * Receiving GLP-1-based pharmacotherapy in combination with remote nutritional counselling * Achieved weight loss of ≥5 (for baseline BMI 28-35 kg/m2) or ≥7% (for baseline BMI≥35kg/m2) after 4 months of GLP-1 based therapy (1st milestone) Exclusion Criteria: * Inability to give written informed consent * Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results * Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding * Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results * Not proficient in German